Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjuvant Lupron Depot in Prostate Cancer
NCT05169112Phase 3Recruiting
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2023
- Primary completion
- Nov 2026
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of leuprolide in prostate cancer (PCa), sponsored by Ottawa Hospital Research Institute. Started Mar 2023; status: recruiting.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05169112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05169112.